Use of Sorafenib and/or Regorafenib in Liver Cancer (Hepatocellular Carcinoma) Subsequent to Another Systemic First-line Treatment
Clinical trial NCT03644511 · TERMINATED
Trial details
- NCT number
- NCT03644511
- Sponsor
- Bayer
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2019-01-24
- Primary completion
- 2019-07-18
- Enrollment
- 3
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.